You are here

  • Home
  • Archive
  • Volume 64, Issue 8
  • Prescription practice of biological drugs in rheumatoid arthritis during the first 3 years of post-marketing use in Denmark and Norway: criteria are becoming less stringent

Citation Tools

Article menu
Download PDFPDF
Concise reports
Prescription practice of biological drugs in rheumatoid arthritis during the first 3 years of post-marketing use in Denmark and Norway: criteria are becoming less stringent

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Hjardem E, Hetland ML, Østergaard M, et al
Prescription practice of biological drugs in rheumatoid arthritis during the first 3 years of post-marketing use in Denmark and Norway: criteria are becoming less stringent
Annals of the Rheumatic Diseases 2005;64:1220-1223.